Volume 72, Issue 2 pp. 321-326
CLINICAL RESEARCH SHORT REPORT

A Preliminary Investigation of Acoustic Features for Remote Monitoring of Respiration in ALS

Kathryn P. Connaghan

Corresponding Author

Kathryn P. Connaghan

Speech and Social Interaction Lab, MGH Institute of Health Professions, Boston, Massachusetts, USA

Correspondence:

Kathryn P. Connaghan ([email protected])

Contribution: Conceptualization, ​Investigation, Writing - original draft, Writing - review & editing, Project administration, Formal analysis

Search for more papers by this author
Marziye Eshghi

Marziye Eshghi

Speech, Physiology, and Neurobiology of Aging and Dementia Lab, MGH Institute of Health Professions, Boston, Massachusetts, USA

Athinoula A. Martinos Centre for Biomedical Imaging, Boston, Massachusetts, USA

Department of Radiology, MGH, Harvard Medical School, Boston, Massachusetts, USA

Contribution: Conceptualization, ​Investigation, Writing - original draft, Writing - review & editing, Formal analysis, Project administration

Search for more papers by this author
Abigail E. Haenssler

Abigail E. Haenssler

Speech and Social Interaction Lab, MGH Institute of Health Professions, Boston, Massachusetts, USA

Speech and Feeding Disorders Lab, MGH Institute of Health Professions, Boston, Massachusetts, USA

Contribution: Writing - review & editing, Formal analysis, ​Investigation

Search for more papers by this author
Jordan R. Green

Jordan R. Green

Speech and Feeding Disorders Lab, MGH Institute of Health Professions, Boston, Massachusetts, USA

Program in Speech and Hearing Bioscience and Technology, Harvard University, Boston, Massachusetts, USA

Contribution: Conceptualization, Writing - review & editing

Search for more papers by this author
Joycelyn Wang

Joycelyn Wang

Speech and Social Interaction Lab, MGH Institute of Health Professions, Boston, Massachusetts, USA

Contribution: Formal analysis, Writing - review & editing

Search for more papers by this author
Zoe Scheier

Zoe Scheier

Healey Center for ALS, Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts, USA

Contribution: Writing - review & editing, Data curation

Search for more papers by this author
Mackenzie Keegan

Mackenzie Keegan

Healey Center for ALS, Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts, USA

Contribution: Writing - review & editing, Data curation

Search for more papers by this author
Alison Clark

Alison Clark

Healey Center for ALS, Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts, USA

Contribution: Data curation, Writing - review & editing

Search for more papers by this author
Jukka-Pekka Onnela

Jukka-Pekka Onnela

Department of Biostatistics, Harvard University, Boston, Massachusetts, USA

Contribution: Methodology, Software, Writing - review & editing

Search for more papers by this author
Katherine M. Burke

Katherine M. Burke

Healey Center for ALS, Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts, USA

MGH Institute of Health Professions, Boston, Massachusetts, USA

Contribution: ​Investigation, Supervision, Writing - original draft, Writing - review & editing

Search for more papers by this author
James D. Berry

James D. Berry

Healey Center for ALS, Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts, USA

Harvard Medical School, School of Medicine, Boston, Massachusetts, USA

Contribution: Conceptualization, Writing - original draft, Writing - review & editing, Supervision, ​Investigation

Search for more papers by this author
First published: 14 May 2025

Funding: This work was supported by the ALS Association, the Winthrop Family Fund for ALS Science at Massachusetts General Hospital, and NIH grants NIDCD K24DC06312 (PI: Jordan R. Green), K23DC019179 (PI: Marziye Eshghi), R15DC018944 (PI: Kathryn P. Connaghan), and F32DC020896 (PI: Abigail E. Haenssler).

Kathryn P. Connaghan and Marziye Eshghi shared first author.

ABSTRACT

Introduction/Aims

There is a substantial need to establish reliable approaches for low-burden at-home monitoring of respiratory function for people with amyotrophic lateral sclerosis (PALS). This preliminary study assessed the potential of acoustic features extracted from a smartphone passage reading task to serve as clinically meaningful outcome measures reflecting instrumental and self-reported respiratory function measures.

Methods

Thirty-six PALS completed an in-clinic slow vital capacity (SVC) task, followed by at-home completion of surveys and audio recording of a reading passage using a smartphone application. Speaking rate and pause features were extracted offline. Correlation analysis evaluated the relationship between the acoustic features and both instrumental (SVC) and self-reported (respiratory subscale of the self-entry version of the ALS Functional Rating Scale-Revised; ALSFRS-RSE) measures of respiratory function. Receiver operator characteristic (ROC) with area under the curve (AUC) analysis evaluated the utility of acoustic features for classifying participants with and without respiratory involvement.

Results

SVC and respiratory self-ratings were significantly correlated with pause, but not rate, measures. Percent pause time was the most strongly correlated acoustic feature with both SVC (r = −0.62) and ALSFRS-RSE respiratory subscale ratings (r = −0.43). ROC analysis revealed that percent pause time classified participants presenting with respiratory involvement based on instrumentation (SVC < 70% predicted [AUC = 0.70]; SVC < 50% predicted [AUC = 0.88]) and self-ratings when using the respiratory ALSFRS-RSE score cut-off of < 11 (AUC = 0.78), but not < 12 (AUC = 0.61).

Discussion

Percent pause time, extracted from a smartphone-recorded passage reading, offers a promising index for remote assessment and monitoring of respiratory function in PALS.

Conflicts of Interest

Jordan Green has served as a paid consultant for several pharmacological and speech technology companies, including Biogen, Google, and Modality.AI Inc. James D. Berry has received research support from Biogen, MT Pharma of America, MT Pharma Holdings of America, and Rapa Therapeutics. He has served as a paid consultant for MT Pharma of America and MT Pharma Holdings of America, Regeneron, Roon, and Alexion. He served as a paid member of a data and safety monitoring board for Sanofi. He acts as an unpaid scientific advisor for the non-profit organizations ALS One and Everything ALS. The remaining authors have no conflicts of interest.

Data Availability Statement

The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.

click me